2nd Quarter - Report

HOLLAND & KNIGHT LLP for PRAXAIR INC

Firm
Client
Income
$120,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

General international tax issues affecting U.S. based multinational corporations.

LobbyistCovered position, as disclosed
JIM DAVIS —
RICHARD M GOLD —
KATHRYN H LEHMAN —
PAOLO MASTRANGELO —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Health Issues HCR

FDA regulation of medical gas; H.R. 2227, Medical Gas Safety Act; S. 3187, the Food and Drug Administration Safety and Innovation Act.

LobbyistCovered position, as disclosed
JIM DAVIS —
KATHRYN H LEHMAN —
JOEL ROBERSON —

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: S. 3187 (112th), H.R. 2227 (112th)

Budget/Appropriations BUD

Advocacy on Tonawanda - Army Corps of Engineers clean up; H.R. 5325 and S.2465, FY13 Energy & Water Appropriations relating to the FUSRAP program.

LobbyistCovered position, as disclosed
RICHARD M GOLD —
DAVID HARRY MANN —

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: S. 2465 (112th), H.R. 5325 (112th)

Energy/Nuclear ENG

Energy efficiency and related legislation; federal helium reserve; S.2344, The Helium Stewardship Act.

LobbyistCovered position, as disclosed
JOHN BUSCHER —
RICHARD M GOLD —
KARL KOCH —
KATHRYN H LEHMAN —
DAVID HARRY MANN —
BETH A VIOLA —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Bills named: S. 2344 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.